Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients Escribano L, Alvarez-Twose I, Sanchez-Muñoz L, Garcia-Montero A, Nuñez R, Almeida J, Jara-Acevedo M, Teodosio C, Garcia-Cosio M, Bellas C, Orfao A. Journal of Allergy and Clinical Immunology 124:514-521. FI: 9.165 (Q1) Fluorescent cisplatin analogues and cytotoxic activity Rodriguez-Fernandez E, Manzano JL, Alonso A, Almendral MJ, Perez-Andres M, Orfao A, Criado JJ. Current Medical Chemistry 16:4314-4327. FI: 4.708 (Q1) Gene expression profiles of meningiomas are associated with tumour cytogenetics and patient outcome Tabernero MD, Maillo A, Gil-Bellosta CJ, Castrillo A, Sousa P, Merino M, Orfao A. Brain Pathology 19:409-420. FI: 5.903 (Q1) Soluble and membrane levels of molecules involved in the interaction between clonally plasma cells and the immunological microenvironment in multiple myeloma and their association with the characteristics of the disease Perez-Andres M, Almeida J, Martin-Ayuso M, De Las Heras N, Moro MJ, Martin-Nuñez G, Galende J, Cello R, Abu in I, Moreno I, Dominguez M, Hernandez J, Mateo G, San Miguel JF, Orfao A. International Journal of Cancer 124:367-375. FI: 4.722 (Q1) The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalban MA, Sureda A, Montejano L, Gutiérrez NC, García De Coca A, De Las Heras N, Mateos MV, López-Borges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, De La Rubia J, Martin A, González Y, Blade J, Lahuerta JJ, Orfao A, San Miguel JF. Blood 114:4369-4372. FI: 10.555 (Q1) Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients Paiva B, Vidriales MB, Pérez JJ, Mateo G, Montalban MA, Mateos MV, Blade J, Lahuerta JJ, Orfao A, San Miguel JF. Haematologica 94:1599-1602. FI: 6.416 (Q1) Human peripheral blood B-cell compartments: a crossroad in B-cell traffic Pérez-Andrés M, Paiva B, Nieto WG, Caraux A, Schmitz A, Almeida J, Vogt RF Jr, Marti GE, Rawstron AC, Van Zelm MC, Van Dongen JJ, Johnsen HE, Klein B, Orfao A, Primary Health Care Group of Salamanca for the Study of MBL. Cytometry 79B:S47-S60. FI: 1.727 (Q2) Prevalence of monoclonal B-cell lymphocytosis: a systematic review Shim YK, Middleton DC, Caporaso NE, Rachel JM, Landgren O, Abbasi F, Raveche ES, Rawstron A, Orfao A, Marti GE, Vogt RF. Cytometry B 79B:S10-S18. FI: 1.730 (Q2) Detection of fusion genes at the protein levelin leukemia patients via the flow cytometric immunobead assay Dekking E, van der Velden VH, Böttcher S, Brüggemann M, Sonneveld E, Koning-Goedheer A, Boeckx N, Lucio P, Sedek L, Szczepanski T, Kalina T, Kovac M, Evans P, Hoogeveen PG, Flores-Montero J, Orfao A, Comans-Bitter WM, Staal FJ, van Dongen JJ. EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708). Best Practice & Research Clinica Haematology 23:333-345. FI: 3.134 (Q2) The WNT signalling pathway regulates Nalm-16 B-cell precursor acute lymphoblastic leukemic cell line survival and etoposide resistance Thiago LS, Costa ES, Lopes DV, Otazu IB, Nowill AE, Mendes FA, Portilho DM, Abreu JG, Mermelstein CS, Orfao A, Rossi MI, Borojevic R. Biomedicine and Pharmacotherapy 64:63-72. FI: 2.238 (Q2)
|
